Every clinical trial starts with a question. At Teckro, we asked “Why can’t clinical trials be more accessible, transparent and simple?”
For all the scientific advancements to deliver medicines and treatments that save lives and improve the quality of life, clinical trials haven’t kept pace with modern innovation. Still reliant on disconnected and inefficient approaches, the way clinical trials are run makes it harder to enroll the right participants, keep sites engaged, and proactively manage risk. That’s why we founded Teckro to simplify and modernize clinical trials.
We’ve come a long way since our initial start with a handful of employees in a small office in Limerick, Ireland. Now with our team distributed across the United States, Europe and the UK, living our values every day is important. It comes down to operating with purpose. By focusing on the right things, our actions are impactful. By being responsive, we can solve problems and build trust. Clinical trials are complex; working with us should be simple.
With our platform, sites enroll the right participants faster and have fewer protocol deviations and violations. It starts with a combination of study content and purpose-built communication so that sites and study monitors can make the best decisions at every step of the trial. Sponsors have the added benefit of gaining visibility into site engagement and early indicators of potential risks to take timely, proactive action.
Our customers range from leading global pharma companies to emerging biotechs.
Teckro supports all phases and is useful as trials move from one phase to the next.
Teckro works for all disease areas, especially complex oncology trials.
Investigators and research staff depend on Teckro answers around the world.
Sites active on Teckro enroll the right participants faster.
Sites engaged on Teckro make better decisions in adherence to the protocol.
Gary Hughes - CEO & Co-Founder